Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report

被引：0
|
作者：
Ippei Miyamoto
Tetsuo Shimizu
Ryo Kusahana
Masayuki Nomoto
Daishi Fujiwara
Tsukasa Nishizawa
Kentaro Hayashi
Yoshiko Nakagawa
Yasuhiro Gon
机构：
[1] Nihon University Itabashi Hospital,Department of Respiratory Medicine
[2] Nihon University School of Medicine,undefined
来源：
BMC Pulmonary Medicine | / 23卷
关键词：
Aminoacyl-tRNA synthetase (ARS); Anti-synthetase syndrome (ASS); Interstitial lung disease; Lung cancer; Immune checkpoint inhibitors (ICIs);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Successful treatment of rapid progressive interstitial lung disease in a case of anti-Zo antibody positive anti-synthetase syndrome
    Li, Yongxia
    Liu, Gang
    Yu, Fengjiao
    Jiang, Yu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (02) : 370 - 375
  • [42] Cyclophosphamide For Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Huapaya, J. A.
    Silhan, L. L.
    Danoff, S. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [43] Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Huapaya, J. A.
    Wiley, K. D.
    Danoff, S. K.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2021, 7 (03) : 243 - 257
  • [44] A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Patel, Puja
    Marinock, Jenna M.
    Ajmeri, Aamir
    Brent, Lawrence H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [45] Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease
    JA Huapaya
    KD Wiley
    SK Danoff
    Current Treatment Options in Rheumatology, 2021, 7 : 243 - 257
  • [46] Rituximab as the first-line therapy in anti-synthetase syndrome-related interstitial lung disease
    Zekic, Tatjana
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (06) : 1015 - 1021
  • [47] Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
    Andersson, Helena
    Sem, Marthe
    Lund, May Brit
    Aalokken, Trond Mogens
    Gunther, Anne
    Walle-Hansen, Ragnhild
    Garen, Torhild
    Molberg, Oyvind
    RHEUMATOLOGY, 2015, 54 (08) : 1420 - 1428
  • [48] Patients with Anti-Synthetase Syndrome Have a Similar Prevalence and Severity of Interstitial Lung Disease to Systemic Sclerosis
    Sohn, Bret
    Annapureddy, Narender
    Dudenhofer, Rosemarie
    Barnado, April
    Crofford, Leslie
    Wilfong, Erin
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [49] ANTI-SYNTHETASE SYNDROME: INTERSTITIAL LUNG DISEASE AS INITIAL MANIFESTATION AND DIAGNOSTIC CHALLENGE OF A CLINICALLY VARIABLE DISORDER
    Cooper, Ryan T.
    Zeman, Joseph E.
    Holtzclaw, Arthur
    CHEST, 2023, 164 (04) : 5534A - 5534A
  • [50] Rituximab as the first-line therapy in anti-synthetase syndrome-related interstitial lung disease
    Tatjana Zekić
    Rheumatology International, 2023, 43 : 1015 - 1021
12345